• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Establishment of a universal grading system for ovarian epithelial carcinoma

Research Project

Project/Area Number 09671727
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionJapanese Foundation for Cancer Research

Principal Investigator

SHIMIZU Yoshio  The Cancer Institute, Asociate, 癌研究所, 研究員 (60260072)

Co-Investigator(Kenkyū-buntansha) HASUMI Katsuhiko  The Cancer Institute, Member/Chief, 癌研究所, 部長 (70134608)
AKIYAMA Futoshi  The Cancer Institute, Department of Pathology, Associate member, 癌研究所・病理部, 主任研究員 (50222550)
Project Period (FY) 1997 – 2000
Keywordsovarian carcinoma / histopathologic grade / prognosis
Research Abstract

The aim of the present study was to establish a universal histopathologic granding system applicable for patients with all histologic types of ovarian epithelial carcinoma(OEC). We first demonstrated that architectural grade(defined by us), nuclear pleomorphism, and mitotic counts were independent and statistically significant prognostic variables for patients with OEC.Then, we awarded points for these three variables, and summed up the scores for a final grade. The scoring system was as follows ; Architectural pattern(predominant) : Glandular=1, Papillary=2, and Solid=3 ; Nuclear pleomorphism : Slight=1, Moderate=2, and Marked =3 ; Mitotic activity(mitotic figures per 10 high-power fields in most active region : 0-9=1, 10-24=2 and 【greater than or equal】 25=3 ; Grade 1=total score 3-5, Grade 2=6 Or 7, and Grade 3=8 or 9. Reproducibility of the scoring was appreciably high (accordance rate : 94%). Subjects included are 538 patients with OEC treated in Cancer Institute Hopspital. 1)The new grade worked as a significant predictor of overall survival in both early and advanced stage disease stratified by FIGO and TNM classification for all histologic types of OEC combined. 2)OEC were classified into distinct two groups, platinum-sensitive(serous, transitional, and endometrioid) and platinum-resistant(mucinous and clear cell). No significant difference in response(CR + PR) to intial platinum-based chemotherapy(CTX) by the new grade. CR rate, however, was significantly lowered in the high-grade disease. Furthermore, progression-free interval, incidence of progression, and the response to the second line CTX was significantly worse in the high-grade (G3)disease. This may indicate that the high-grade disease is more likely to develop acquired resistance These results were reflected in the difference of survival of OEC patients by the new grade. 3)The new grade also worked as a significant prognostic factor for lymph node metastasis.

  • Research Products

    (11 results)

All Other

All Publications (11 results)

  • [Publications] Shimizu Y: "Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma"Jpn J Chem Chemalher. 24. 61-69 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu Y et al: "Toward the development of a universal grading system for ovarian Epithelial Carcinoma"Cancer. 82. 893-901 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu Y et al: "Prognostic significance of histopathologic featores"Gopnecol Oncol. 70. 2-12 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu Y et al.: "Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma"J Clin Oncol. 16. 1869-1878 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水 敬生: "卵巣腫瘍の病理組織学"産科と婦人科. 66. 49-59 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y Shimizu et al.: "The Mechanism of cisplatr resistance and its ciraemventior"Yoshihiro Kikuchi. 457 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu Y, et al: "Individualized Chemotherapeutic Regimen for Each Histological Subtype of Ovarian Carcinoma"Jpn J Cancer Chemother. 24 : Supplment l. 61-69 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu Y, et al: "Cytotoxic agents active against mucinous adenocarcinoma of the ovary"Oncol Reports. 5. 99-101 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu Y, et al: "Toward the development of a universal grading system for ovarian epithelial carcinoma. Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up"Cancer. 82. 893-901 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu Y, et al: "Toward the development of a universal grading system for ovarian epithelial carcinoma. I.Prognostic significance of histopathologic features-----Problems involved in the architectural grading system"Gynecol Oncol. 70. 2-12 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu Y, et al: "Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma"J Clin Oncol. 16. 1869-1878 (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi